ResearcherEuropean Society of AnaesthesiologyNo recent work listed

Zhirajr Mokini

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5510-5649; OpenAlex author ID A5071685705. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer? Co-author DOI 10.3390/medicina58081102 ↗
Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. Co-author DOI 10.3390/cancers13163946 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alessandro Cama · 2 shared papers, 2021–2022 · strength 0.39
- Paper Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer? DOI 10.3390/medicina58081102 ↗
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946 ↗
Patrice Forget · 1 shared paper, 2022 · strength 0.26
- Paper Anesthetics and Long Term Cancer Outcomes: May Epigenetics Be the Key for Pancreatic Cancer? DOI 10.3390/medicina58081102 ↗
Nicola Tinari · 1 shared paper, 2021 · strength 0.13
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946 ↗
Davide Brocco · 1 shared paper, 2021 · strength 0.13
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946 ↗
Rosalba Florio · 1 shared paper, 2021 · strength 0.13
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946 ↗
Laura De Lellis · 1 shared paper, 2021 · strength 0.13
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946 ↗
Serena Veschi · 1 shared paper, 2021 · strength 0.13
- Paper Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates. DOI 10.3390/cancers13163946 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.